Literature DB >> 34035668

COVID-19 outbreak in a personal service setting in Kingston, Ontario, 2020.

Anthony Li1,2, Stéphanie Parent1,2, Azim Kasmani1,3, T Hugh Guan1,3, Kieran Moore1,3.   

Abstract

BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, Ontario created a three-phase reopening framework for the economy. Outbreaks were expected at each phase. One week after Phase Two of reopening in the provincial public health administration region of Kingston, Frontenac, Lennox and Addington (KFL&A), a positive case was reported after three weeks of zero new COVID-19 cases. The objective of this report is to describe this COVID-19 outbreak, linked to a personal service setting (PSS), and the public health response to contain the outbreak.
METHODS: The outbreak investigation included all COVID-19 cases in KFL&A between June 20, 2020 and July 3, 2020. Public health inspectors and nurses were rapidly deployed to inspect the PSS. A multimodal approach to high-volume testing involved fixed assessment centres, drive-through testing capacity and targeted testing at the outbreak site. Testing was conducted through a real-time polymerase chain reaction assay at the local Public Health Ontario laboratory.
RESULTS: Thirty-seven cases were associated with the outbreak: 38% through direct PSS exposure; 32% through household contact; and 30% through social and workplace contact. A superspreading event contributed to 38% of total cases. The majority of cases were in the low to mid-quintiles when analyzed for material deprivation. Testing rates increased four-fold compared to the prior baseline weeks in response to media attention and public health messaging, resulting in a low percent positivity.
CONCLUSION: The interplay of aggressive accessible testing, quick lab turnaround time, contact tracing within 24 hours of positive laboratory results as per provincial standards, frequent public communication, rapid inspections, mandatory self-isolation and face coverings were measures successful in halting the outbreak. Inspections or self-audits should be required at all PSSs prior to reopening and outbreak management must work with PSSs to reduce the possibility of superspreading events.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; case and contact management; infection prevention and control; outbreak; personal service setting; public health; superspreading event

Year:  2021        PMID: 34035668      PMCID: PMC8127683          DOI: 10.14745/ccdr.v47i04a06

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  26 in total

Review 1.  Risk for hepatitis B and C virus transmission in nail salons and barbershops and state regulatory requirements to prevent such transmission in the United States.

Authors:  Jun Yang; Keri Hall; Azizeh Nuriddin; Diane Woolard
Journal:  J Public Health Manag Pract       Date:  2014 Nov-Dec

2.  High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020.

Authors:  Lea Hamner; Polly Dubbel; Ian Capron; Andy Ross; Amber Jordan; Jaxon Lee; Joanne Lynn; Amelia Ball; Simranjit Narwal; Sam Russell; Dale Patrick; Howard Leibrand
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-15       Impact factor: 17.586

3.  The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study.

Authors:  Trystan Leng; Connor White; Joe Hilton; Adam Kucharski; Lorenzo Pellis; Helena Stage; Nicholas G Davies; Matt J Keeling; Stefan Flasche
Journal:  Wellcome Open Res       Date:  2021-03-29

4.  Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.

Authors:  Kipruto Chesang; Sureyya Hornston; Odylia Muhenje; Teresa Saliku; Joy Mirjahangir; Amanda Viitanen; Helgar Musyoki; Christine Awuor; George Githuka; Naomi Bock
Journal:  PLoS Med       Date:  2017-12-27       Impact factor: 11.069

5.  Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.

Authors:  Nathan W Furukawa; John T Brooks; Jeremy Sobel
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

6.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

7.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.

Authors:  Lucy Rivett; Sushmita Sridhar; Dominic Sparkes; Matthew Routledge; Nick K Jones; Ian G Goodfellow; Stephen Baker; Michael P Weekes; Sally Forrest; Jamie Young; Joana Pereira-Dias; William L Hamilton; Mark Ferris; M Estee Torok; Luke Meredith; Martin D Curran; Stewart Fuller; Afzal Chaudhry; Ashley Shaw; Richard J Samworth; John R Bradley; Gordon Dougan; Kenneth Gc Smith; Paul J Lehner; Nicholas J Matheson; Giles Wright
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

8.  Household transmission of SARS-CoV-2.

Authors:  Zhongliang Wang; Wanli Ma; Xin Zheng; Gang Wu; Ruiguang Zhang
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

9.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Takeshi Miyama; Ayako Suzuki; Sung-Mok Jung; Katsuma Hayashi; Ryo Kinoshita; Yichi Yang; Baoyin Yuan; Andrei R Akhmetzhanov; Natalie M Linton
Journal:  Int J Infect Dis       Date:  2020-03-14       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.